<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Aimei Health Technology Co., Ltd Right — News on 6ix</title>
    <link>https://6ix.com/company/aimei-health-technology-co-ltd-right</link>
    <description>Latest news and press releases for Aimei Health Technology Co., Ltd Right on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 10:45:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/aimei-health-technology-co-ltd-right" rel="self" type="application/rss+xml" />
    <item>
      <title>AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT</title>
      <link>https://6ix.com/company/aimei-health-technology-co-ltd-right/news/aimei-health-technology-co-ltd-receives-nasdaq-notice-regarding-delayed-annual-report-1</link>
      <guid isPermaLink="true">https://6ix.com/company/aimei-health-technology-co-ltd-right/news/aimei-health-technology-co-ltd-receives-nasdaq-notice-regarding-delayed-annual-report-1</guid>
      <pubDate>Tue, 21 Apr 2026 10:45:00 GMT</pubDate>
      <description>New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the C</description>
    </item>
  </channel>
</rss>